Karyopharm Therapeutics News

Latest Karyopharm Therapeutics Stock News & KPTI Headlines

Karyopharm Therapeutics Inc. Announces Planned Merger with Ayrmid Ltd. to Strengthen Company for the Future

13 days ago | prnewswire.com

Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis

2 months ago | gurufocus.com

Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO® (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis

2 months ago | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI

3 months ago | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI

3 months ago | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI

3 months ago | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI

3 months ago | globenewswire.com

Karyopharm Therapeutics Inc. (KPTI) Q2 2026 Earnings Call Transcript

3 months ago | seekingalpha.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Karyopharm Therapeutics Inc. - KPTI

3 months ago | prnewswire.com

Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Beats Revenue Estimates

3 months ago | zacks.com

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

Market Closed

KPTI

Karyopharm Therapeutics

$ 0.01740

-56.50%

Last 24H

Trading with leverage comes with a high risk and may not be suitable for everyone.

Portfolio

Updated 4 days ago

Top

Gainers

Losers

Symbol

Last Price

24H CNG

Karyopharm Therapeutics News

Latest Karyopharm Therapeutics Stock News & KPTI Headlines

Download App

People Also Watch

Explore our Tools